AQR Capital Management »

Arcutis Biotherapeutics shares owned by AQR Capital Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $934k 289k 3.23

More positions owned by AQR Capital Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Cisco Systems (CSCO)
Adobe Systems Incorporated (ADBE)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Pulte (PHM)
Cigna Corp (CI)
Humana (HUM)
CVS Caremark Corporation (CVS)

View all positions for AQR Capital Management

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Vanguard Group
Franklin Resources
Millennium Management
Opaleye Management
Jennifer Ranahan
Deutsche Bank Aktiengesellschaft
Tejara Capital
Two Sigma Investments
Goldman Sachs Group
Charles Schwab Investment Management
Federated Investors
AMI Asset Management Corporation
Walleye Trading Advisors

View all funds holding Arcutis Biotherapeutics